Effect of NG-nitro-L-arginine on the anti-convulsant action of four second-generation antiepileptic drugs in pentetrazole-induced clonic seizures in mice

Pharmacological Reports

Volumn 59, Issue 4, 2007, Pages 467-473

  Łuszczki, Jarogniew J ^a   Szadkowski, Marcin ^b   Czuczwar, Stanisław J ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b First Department of Internal Medicine with Dialysis Station   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Gabapentin; Mice; NG nitro L arginine; Nitric oxide; Oxcarbazepine; Pentetrazole induced seizures; Tiagabine; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; N(G) NITROARGININE; OXCARBAZEPINE; PENTETRAZOLE; TIAGABINE; VIGABATRIN; 4 AMINOBUTYRIC ACID; AMINE; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; NIPECOTIC ACID DERIVATIVE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; STATISTICAL SIGNIFICANCE; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; PSYCHOMOTOR PERFORMANCE; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

AMINES; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MICE; NIPECOTIC ACIDS; NITRIC OXIDE SYNTHASE; NITROARGININE; PENTYLENETETRAZOLE; PSYCHOMOTOR PERFORMANCE; SEIZURES; TIME FACTORS; VIGABATRIN;

EID: 35048903976     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baran L, Siwanowicz J, Przegaliński E: Effect of nitric oxide synthase inhibitors and molsidomine on the anticonvulsant activity of some antiepileptic drugs. Pot J Pharmacol, 1997, 49, 363-368.
2. Boissier JR, Tardy J, Diverres JC: Une nouvelle methode simple pour explorer l'action «tranquilisante»: le test de la cheminee. Med Exp (Basel), 1960, 3, 81-84.
3. Borowicz KK, Łuszczki J, Kleinrok Z, Czuczwar SJ: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm, 2000, 107, 1117-1126.
4. Borowicz KK, Starownik R, Kleinrok Z, Czuczwar SJ: The influence of L-NG-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J Neural Transm, 1998, 105, 1-12.
5. Czuczwar SJ, Tutka P, Klonowski P, Kleinrok Z: N(G)-nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol. Eur J Pharmacol, 1999, 366, 137-142.
6. De Sarro G, Gareri P, Falconi U, De Sarro A: 7-Nitroindazole potentiates the antiseizure activity of some anti-convulsants in DBA/2 mice. Eur J Pharmacol, 2000, 394, 275-288.
7. Dwyer MA, Bredt DS, Snyder SH: Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun, 1991, 176, 1136-1141.
8. Feng Y, LeBlanc MH, Regunathan S: Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci Lett, 2005, 390, 129-133.
9. Fukami S, Uchida I, Mashimo T, Takenoshita M, Yoshiya I: Gamma subunit dependent modulation by nitric oxide (NO) in recombinant GABAA receptor. Neuroreport, 1998, 9, 1089-1092.
10. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci, 1997, 20, 132-139.
11. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ: Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem, 1977, 29, 797-802.
12. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
13. Lonart G, Wang J, Johnson KM: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol, 1992, 220, 271-272.
14. Löscher W, Hönack D, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res, 1991, 8, 171-189.
15. Löscher W, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Res, 1991, 9, 1-10.
16. Łuszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Późniak G, Czuczwar K, Czuczwar SJ: 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm, 2006, 113, 1157-1168.
17. G-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep, 2006, 58, 955-960.
18. Łuszczki JJ, Czuczwar SJ: How significant is the difference between drug doses influencing the threshold for electroconvulsious? Pharmacol Rep, 2005, 57, 782-786.
19. Łuszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn Schmiedebergs Arch Pharmacol, 2006, 373, 169-181.
20. Łuszczki JJ, Sacharuk A, Wojciechowska A, Andres MM, Dudra-Jastrzebska M, Mohamed M, Sawicka KM et al.: 7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Pharmacol Rep, 2006, 58, 660-671.
21. Łuszczki JJ, Wójcik-Ćwikła J, Andres MM, Czuczwar SJ: Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology, 2005, 30, 958-973.
22. McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF: Oxcarbazepine: mechanisms of action. Epilepsia, 1994, 35, Suppl 3, S5-S9.
23. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J, 1995, 9, 1319-1330.
24. Moncada S, Higgs A, Furchgott R: International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev, 1997, 49, 137-142.
25. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science, 1994, 263, 973-977.
26. Montecot C, Borredon J, Seylaz J, Pinard E: Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate. J Cereb Blood Flow Metab, 1997, 17, 94-99.
27. Morris SM: Enzymes of arginine metabolism. J Nutr, 2004, 134, Suppll 10, 2743S-2747S.
28. Paul V, Jayakumar AR: A role of nitric oxide as an inhibitor of gamma-aminobutyric acid transaminase in rat brain. Brain Res Bull, 2000, 51, 43-46.
29. Przegaliński E, Baran L, Siwanowicz J: The role of nitric oxide in the kainate-induced seizures in mice. Neurosci Lett, 1994, 170, 74-76.
30. Segovia G, Mora F: Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull, 1998, 45, 275-279.
31. Smith SE, Man CM, Yip PK, Tang E, Chapman AG, Meldrum BS: Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol, 1996, 119, 165-173.
32. Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J: Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav, 2004, 77, 345-349.
33. Szabo C: Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull, 1996, 41, 131-141.
34. Tutka P, Klonowski P, Dzieciuch J, Kleinrok Z, Czuczwar SJ: N(G)-nitro-L-arginine differentially affects glutamate- or kainate-induced seizures. Neuroreport, 1996, 7, 1605-1608.
35. Tutka P, Łuszczki J, Kleinrok Z, Arent K, Wielosz M: Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J Neural Transm, 2002, 109, 455-466.
36. Tutka P, Młynarczyk M, Z̊ółkowska D, Kleinrok Z, Wielosz M, Czuczwar SJ: Nitric oxide and convulsions in 4-aminopyridine-treated mice. Eur J Pharmacol, 2002, 437, 47-53.
37. Yamamoto H: Preventive effect of N(G)-nitro-L-arginine against L-cysteine-induced seizures in mice. Toxicol Lett, 1996, 84, 1-5.